230
Participants
Start Date
February 29, 2008
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
PH-797804
PH-797804 at four dose levels
Placebo
Placebo
Pfizer Investigational Site, Budapest
Pfizer Investigational Site, La Plata
Pfizer Investigational Site, Rosario
Pfizer Investigational Site, Camperdown
Pfizer Investigational Site, Durban
Pfizer Investigational Site, Durban
Pfizer Investigational Site, Daw Park
Pfizer Investigational Site, Nedlands
Pfizer Investigational Site, Deszk
Pfizer Investigational Site, Pécs
Pfizer Investigational Site, Bloemfontein
Pfizer Investigational Site, Szombathely
Pfizer Investigational Site, Athens
Pfizer Investigational Site, Marseille
Pfizer Investigational Site, Tábor
Pfizer Investigational Site, Perpignan
Pfizer Investigational Site, Yaroslavl
Pfizer Investigational Site, Yaroslavl
Pfizer Investigational Site, Valparaíso
Pfizer Investigational Site, Talca
Pfizer Investigational Site, Providencia
Pfizer Investigational Site, Buenos Aires
Pfizer Investigational Site, Buenos Aires
Pfizer Investigational Site, Ciudad Autonoma de Buenos Aires (caba)
Pfizer Investigational Site, Vancouver
Pfizer Investigational Site, Winnipeg
Pfizer Investigational Site, Hamilton
Pfizer Investigational Site, Kingston
Pfizer Investigational Site, Sainte-Foy
Pfizer Investigational Site, Cvikov
Pfizer Investigational Site, Kutná Hora
Pfizer Investigational Site, Liberec
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Strakonice
Pfizer Investigational Site, Lille
Pfizer Investigational Site, Montpellier
Pfizer Investigational Site, Heraklion
Pfizer Investigational Site, Larissa
Pfizer Investigational Site, Budapest
Pfizer Investigational Site, Almere Stad
Pfizer Investigational Site, Zutphen
Pfizer Investigational Site, Anyang
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Edinburgh
Lead Sponsor
Pfizer
INDUSTRY